Mastodon

Berocca® Plus (Tablets) Instructions for Use

Marketing Authorization Holder

BAYER, JSC (Russia)

Manufactured By

Delpharm Gaillard (France)

Contact Information

BAYER AG (Germany)

ATC Code

A11AA04 (Multivitamins and trace elements)

Dosage Forms

Bottle OTC Icon Berocca® Plus Effervescent tablets with orange flavor: 15 or 30 pcs.
Film-coated tablets: 30 pcs.

Dosage Form, Packaging, and Composition

Effervescent tablets with orange flavor are flat-cylindrical, from pale orange to light orange in color, with inclusions of darker and lighter color; they dissolve in water with the release of bubbles, forming a solution with an orange odor.

1 tab.
Ascorbic acid (vit. C) 500 mg
Thiamine hydrochloride (vit. B1)1 15 mg
Riboflavin (vit. B2)2 15 mg
Nicotinamide (vit. B3) 50 mg
Pantothenic acid (vit. B5)3 23 mg
Pyridoxine hydrochloride (vit. B6) 10 mg
Biotin 0.15 mg
Folic acid (vit. B9) 0.4 mg
Cyanocobalamin (vit. B12)4 0.01 mg
Calcium (in the form of calcium carbonate and calcium pantothenate)5 100 mg
Magnesium (in the form of heavy magnesium carbonate and magnesium sulfate dihydrate)6 100 mg
Zinc (in the form of zinc citrate trihydrate)7 10 mg

Excipients: anhydrous citric acid – 1700 mg, sodium bicarbonate – 840 mg, anhydrous sodium carbonate – 60 mg, sodium chloride – 40 mg, acesulfame potassium – 20 mg, aspartame – 25 mg, beet red (E162) – 30 mg, beta-carotene (E160a) – 40 mg, orange flavor – 100 mg, polysorbate 60 – 0.9 mg, mannitol – 16.848 mg, isomalt – 265.531 mg, sorbitol – 155.3027 mg.

15 pcs. – aluminum cylinders (1) – cardboard packs.
15 pcs. – aluminum cylinders (2) – cardboard packs.
15 pcs. – polypropylene cylinders (1) – cardboard packs.
15 pcs. – polypropylene cylinders (2) – cardboard packs.

1in the form of thiamine monophosphoric acid ester chloride – 18.54 mg;
2 in the form of riboflavin sodium phosphate – 20.51 mg;
3 in the form of calcium pantothenate – 25 mg;
4in the form of cyanocobalamin 0.1% – 10 mg;
5 in the form of granulated calcium carbonate (calcium carbonate and maltodextrin) – 97.69 mg and calcium pantothenate – 2.31 mg;
6in the form of granulated magnesium carbonate (heavy magnesium carbonate and pregelatinized corn starch) – 49 mg and magnesium sulfate dihydrate – 51 mg;
7 in the form of zinc citrate trihydrate.


Film-coated tablets from pale orange to grayish-orange in color, oblong, biconvex.

1 tab.
Thiamine (vit. B1)1 15 mg
Riboflavin (vit. B2) 15 mg
Nicotinamide (vit. B3) 50 mg
Pantothenic acid (calcium pantothenate) (vit. B5)2 23 mg
Pyridoxine hydrochloride (vit. B6) 10 mg
Biotin 0.15 mg
Folic acid (vit. B9) 0.4 mg
Cyanocobalamin (vit. B12)3 0.01 mg
Ascorbic acid (vit. C) 500 mg
Calcium (in the form of calcium carbonate and calcium pantothenate) 100 mg
Magnesium (in the form of magnesium hydroxycarbonate and light magnesium oxide) 100 mg
Zinc (in the form of zinc citrate trihydrate) 10 mg

Excipients: lactose monohydrate – 94.3 mg, povidone K90 (E1201) – 45 mg, croscarmellose sodium (E468) – 44 mg, mannitol (E421) – 25.45 mg, talc (E553b) – 15 mg, magnesium stearate (E572) – 14 mg.

Shell composition Opadry II brown4 – 43 mg (polydextrose (E1200), hypromellose (E464), titanium dioxide (E171), fractionated coconut oil, yellow iron oxide dye (E172), red iron oxide dye (E172), black iron oxide dye (E172)).

10 pcs. – blisters (3) – cardboard packs.

1 in the form of anhydrous thiamine hydrochloride – 15 mg, in the form of thiamine nitrate – 14.57 mg;
2 in the form of pantothenic acid – 23 mg, in the form of calcium pantothenate – 25 mg;
3 in the form of cyanocobalamin 0.1% WS;
4 Opadry II brown: polydextrose (E1200) 31.25%, hypromellose (E464) 31.25%, titanium dioxide (E171) 26.7%, fractionated coconut oil 6.25%, yellow iron oxide dye (E172) 3.14%, red iron oxide dye (E172) 1.35%, black iron oxide dye (E172) 0.06%.

Clinical-Pharmacological Group

Multivitamins with macro- and microelements

Pharmacotherapeutic Group

Multivitamin agent + minerals

Pharmacological Action

Multivitamins with macro and microelements. The pharmacological action is due to the vitamins and minerals included in the composition.

B vitamins are involved in many metabolic reactions, including the synthesis of neurotransmitters.

Vitamin C (Ascorbic acid) is a biological antioxidant and plays an important role in the inactivation of free radicals, increases iron absorption in the small intestine, affects folic acid metabolism and leukocyte function. It stimulates the formation of connective tissue, bone tissue, and normalizes capillary permeability.

Calcium is involved in many physiological processes, the functioning of enzyme systems, and the transmission of nerve impulses in combination with magnesium and vitamin B6.

Magnesium is involved in various reactions, including protein synthesis, fatty acid metabolism, and sugar oxidation.

Zinc as a catalyst activates more than 200 enzymes and is a component of many proteins, hormones, neuropeptides, hormone receptors, and also directly participates in the synthesis of coenzymes, derivatives of pyridoxine.

Indications

Deficiency or conditions accompanied by an increased need for B vitamins, vitamin C and zinc.

It is used for conditions accompanied by a deficiency or increased need for vitamins: during increased physical exertion, during prolonged nervous strain and stress; with inadequate and unbalanced nutrition (restrictive diets); in elderly people; with chronic alcoholism.

ICD codes

ICD-10 code Indication
E51 Thiamine deficiency
E52 Nicotinic acid deficiency [pellagra]
E53.0 Riboflavin deficiency
E53.1 Pyridoxine deficiency
E53.8 Deficiency of other specified B group vitamins
E54 Deficiency of ascorbic acid
E60 Alimentary zinc deficiency
E63.1 Disparate intake of food elements
F10.2 Chronic alcoholism
F43.9 Reaction to severe stress, unspecified
Z73.0 Burn-out
Z73.3 Stress, not elsewhere classified (physical and mental strain)
ICD-11 code Indication
5B56.Z Vitamin C deficiency, unspecified
5B5A.Z Vitamin B1 deficiency, unspecified
5B5B Vitamin B2 deficiency
5B5D Vitamin B6 deficiency
5B5E Folic acid deficiency
5B5F Vitamin B13 deficiency
5B5G Biotin deficiency
5B5H Pantothenic acid deficiency
5B5J Choline deficiency
5B5K.2 Zinc deficiency
5B7Z Malnutrition, unspecified
6B4Z Disorders specifically associated with stress, unspecified
6C40.2Z Alcohol dependence, unspecified
6C40.Z Disorders due to alcohol use, unspecified
8D44.Y Other specified alcohol-related neurological disorders
QD85 Burn-out
QE01 Stress, not elsewhere classified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer orally.

Take one tablet daily.

For effervescent tablets, completely dissolve one tablet in a glass (200 mL) of water. Consume the resulting solution immediately.

For film-coated tablets, swallow the tablet whole with a sufficient amount of water. Do not chew.

Adhere to a daily intake schedule for consistent therapeutic effect.

The standard treatment course is 30 days.

The decision for a repeated course must be made by a physician based on individual patient assessment.

Do not exceed the recommended daily dose.

This product is not intended for children under 15 years of age.

It is not intended for use by pregnant or breastfeeding women.

Consult a physician before use if you are taking other medications or have underlying health conditions.

Adverse Reactions

From the digestive system, mild transient gastrointestinal disorders are possible.

Allergic reactions: rarely ( <1/10,000) – urticaria, rash, laryngeal edema, anaphylactic shock.

From the hematopoietic system: in patients with glucose-6-phosphate dehydrogenase deficiency, Ascorbic acid may cause hemolytic anemia.

From the nervous system headache, dizziness, insomnia, excitability.

Contraindications

Hypersensitivity to the components; hypercalcemia; hypermagnesemia; urolithiasis (nephrolithiasis, urolithiasis); hemochromatosis; hyperoxaluria; impaired renal function; glucose-6-phosphate dehydrogenase deficiency; fructose intolerance; children under 15 years of age.

With caution should be prescribed to patients with atrophic gastritis, intestinal diseases, pancreatic diseases, with vitamin B12 malabsorption syndrome or congenital deficiency of intrinsic Castle factor.

Use in Pregnancy and Lactation

This complex is not intended for use in pregnant or breastfeeding women.

Use in Renal Impairment

The drug is contraindicated in cases of impaired renal function, urolithiasis (nephrolithiasis, urolithiasis).

Pediatric Use

The use of the drug is contraindicated in children under 15 years of age.

Special Precautions

Ascorbic acid may affect the results of the urine glucose test, even though it does not affect blood glucose levels. Vitamin C intake should be discontinued several days before such tests.

Urine may turn yellow, which has no clinical significance and is explained by the presence of riboflavin in the drug.

The drug does not contain fat-soluble vitamins.

If there is an intolerance to certain sugars, the patient should consult a doctor before taking the drug.

The recommended daily dose of the drug should not be exceeded. Patients taking other medications should consult a doctor before starting to take this complex.

Drug Interactions

Pyridoxine in a dose exceeding 5 mg may neutralize the effect of levodopa in patients with parkinsonism. However, such antagonism is not observed when levodopa is used in combination with a decarboxylase inhibitor (e.g., benserazide, carbidopa).

Thiosemicarbazone and 5-fluorouracil neutralize the effect of thiamine.

Antacid drugs inhibit the resorption of thiamine.

Neomycin, aminosalicylic acid and histamine H2-receptor blockers reduce the absorption of cyanocobalamin.

Acetylsalicylic acid reduces the absorption of ascorbic acid by approximately one third.

Oral contraceptives may reduce serum levels of cyanocobalamin, folic acid, pyridoxine, and ascorbic acid.

Some patients taking deferoxamine and ascorbic acid daily at a dose of 500 mg may experience transient left ventricular dysfunction.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS